Aldeyra Therapeutics

ALDX • NASDAQ • Stock Fundamentals

Aldeyra Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Todd C. Brady, with a market cap of $103.1M.

Market Cap$103.1M

Employees10.0

CEOTodd C. Brady

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026

Next EarningsAug 6, 2026 · in 2 monthsAfter Market Close · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Aldeyra Therapeutics

Aldeyra Therapeutics (ALDX) has a market capitalization of $103.1M and trades on NASDAQ.

Aldeyra Therapeutics has approximately 10 employees.